India Drug-Pricing Authority To Give Pharmas Incentives To Improve Products (India)
This article was originally published in PharmAsia News
Executive Summary
India's National Pharmaceutical Pricing Authority plans a new system that would require drug makers to undergo more scrutiny on whether new ingredients and packaging materials improve the quality of their drug. The changes are intended to give pharmas incentives to make those changes because they then would be able to charge a higher price for their product if the changes improve quality. Drug makers have said the price controls placed on them in India kept the companies from making changes to extend the shelf life of their drugs and enhance their qualities. (Click here for more